ALLMedicine™ Splenectomy Center

Mar 18th, 2023 - The purpose of this study is to provide an updated description of demographics, technical details and clinical outcomes of 101 consecutive branch renal artery repairs in 98 patients using cold perfusion. Single institution, retrospective analysis ...

Mar 13th, 2023 - Splenic B-cell lymphomas are rare and understudied entities. Splenectomy is frequently required for specific pathological diagnosis in patients with splenic B-cell lymphomas other than classical hairy cell leukemia (cHCL), and can be effective and...

Mar 13th, 2023 - Medication Summary The treatment of acute immune thrombocytopenia (ITP) requires considerable individualization. [94] General approaches for children with acute ITP and adults with chronic ITP are discussed below. Recommended general approach for ...

Mar 13th, 2023 - History The medical history in a patient with a clinical suspicion of immune thrombocytopenia (ITP) should focus on the following: Factors that suggest another disease for which thrombocytopenia is a complication Signs and symptoms that differenti...

Mar 13th, 2023 - Medical Care The goal of medical care for immune thrombocytopenia (ITP) is to increase the platelet count to a safe level, permitting patients to live normal lives while awaiting spontaneous or treatment-induced remission. ITP has no cure, and rel...

Feb 23rd, 2008 - Although laparoscopic splenectomy (LS) has become the standard approach for most splenectomy cases, some areas still remain controversial. To date, the indications that preclude laparoscopic splenectomy are not clearly defined. In view of this, th...

Mar 2nd, 2023 - Due to shortage of deceased donor organs, LDLT (living donor living transplantation) is gaining importance all over world. Previous studies have showed poor outcomes with donor grafts having GRWR (graft to recipient weight ratio) < 0.8 due to deve...

Feb 28th, 2023 - Data will be submitted to the Registry via electronic case report forms (eCRFs). Relevant datasets, such as historical trial data, claims, medical records, or central lab data will be electronically integrated into the Registry or Registry reporti...

Feb 17th, 2023 - ACTIVATE-KidsT (AG348-C-022) is a multicenter study designed to evaluate the efficacy and safety of treatment with mitapivat compared with placebo in pediatric participants with pyruvate kinase deficiency (PK deficiency) who are regularly receivin...

Feb 9th, 2023 - Pyruvate kinase deficiency is the most common red cell glycolytic enzyme defect causing hereditary non-spherocytic hemolytic anemia, caused by mutations in the PKLR gene. PKLR encodes a pyruvate kinase that catalyzes the transphosphorylation of ph...

Feb 9th, 2023 - Ovarian cancer is the most common cause of death in gynecological cancer. Approximately 75% of epithelial ovarian cancers are detected at an advanced stage. Metastasis and spread are mostly through transperitoneal planting and neighborhood by shed...

Jan 11th, 2023 - Almost one-third of patients undergoing omentectomy for peritoneal metastases had occult omental metastases, supporting routine omentectomy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC), authors of a retr...

Oct 11th, 2022 - Transcript: Morey Blinder, MD:Howard, do you want to just comment a little bit about romiplostim? You have broad clinical experience such as clinical trials. Howard Liebman, MD: The funny thing is that when we did the clinical trial, the patie...

Oct 11th, 2022 - Transcript: Morey Blinder, MD:Before we leave this topic, I would like to talk about thrombosis as an adverse event. I recall a number of years ago, I was at an ASH [American Society of Hematology] meeting where I saw 2 hematologists almost come ...

Oct 11th, 2022 - Transcript: Morey Blinder, MD:Let's move on and talk about some of the longer-term issues. How does treatment duration affect platelet and patient outcomes? Are there any benefits for long-term therapy based on the mechanism of action, say? Is th...

Oct 11th, 2022 - Transcript: Morey Blinder, MD: Let me just ask one quick question about COVID-19–related ITP [immune thrombocytopenia], and that is about people who have stable ITP and the effect on the vaccine. I know there’ve been a couple of recent series pub...